Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Mueller

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
The Pediatric Infectious Disease Journal|February 1, 1996
Role of tissue diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infectionS Izraeli, B U Mueller, A Ling, et al.
The Journal of Pediatrics|October 1, 1992
Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infectionR N Husson, Y Chung, J Mordenti, et al.
Blood|October 7, 2000
PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA bindingP Zhang, X Zhang, A Iwama, et al.
Pediatrics|February 1, 1994
Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infectionR N Husson, B U Mueller, M Farley, et al.
Lancet (London, England)|December 6, 2001
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacyM A Polis, I A Sidorov, C Yoder, et al.
AIDS (London, England)|January 6, 1999
Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatmentC Chougnet, K R Fowke, B U Mueller, et al.
Blood|April 28, 2005
CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)Daniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 26, 2006
[Intravascular optical coherence tomography: differentiation of atherosclerotic plaques and quantification of vessel dimensions in crural arterial specimens]O A Meissner, J Rieber, G Babaryka, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2004
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of CalreticulinDaniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
The Journal of Infectious Diseases|June 1, 1996
Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infectionS Sei, H Akiyoshi, J Bernard, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
The Pediatric Infectious Disease Journal|February 1, 1996
Role of tissue diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infectionS Izraeli, B U Mueller, A Ling, et al.
The Journal of Pediatrics|October 1, 1992
Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infectionR N Husson, Y Chung, J Mordenti, et al.
Blood|October 7, 2000
PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA bindingP Zhang, X Zhang, A Iwama, et al.
Pediatrics|February 1, 1994
Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infectionR N Husson, B U Mueller, M Farley, et al.
Lancet (London, England)|December 6, 2001
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacyM A Polis, I A Sidorov, C Yoder, et al.
AIDS (London, England)|January 6, 1999
Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatmentC Chougnet, K R Fowke, B U Mueller, et al.
Blood|April 28, 2005
CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)Daniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 26, 2006
[Intravascular optical coherence tomography: differentiation of atherosclerotic plaques and quantification of vessel dimensions in crural arterial specimens]O A Meissner, J Rieber, G Babaryka, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2004
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of CalreticulinDaniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
The Journal of Infectious Diseases|June 1, 1996
Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infectionS Sei, H Akiyoshi, J Bernard, et al.
Pageof 22